Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that "compare favourably'' with the two mRNA vaccines already on the market from Pfizer and Moderna.
Sanofi will build a new vaccine manufacturing facility in Toronto, Ontario, to increase the supply of its Fluzone High-Dose quadrivalent influenza vaccine in Canada, the U.S. and Europe.
